AGEN
AGEN
NASDAQ · Biotechnology

Agenus Inc

$6.95
+0.08 (+1.16%)
Financial Highlights (FY 2026)
Revenue
171.58M
Net Income
174.2K
Gross Margin
99.1%
Profit Margin
0.1%
Rev Growth
+5.2%
D/E Ratio
0.41
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 99.1% 99.1% 42.9% 42.9%
Operating Margin 70.5% 63.5% -12.1% -11.8%
Profit Margin 0.1% 0.1% -13.6% -13.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 171.58M 163.07M 22.23M 24.20M
Gross Profit 170.06M 161.62M 9.53M 10.37M
Operating Income 121.04M 103.53M -2,685,737 -2,845,163
Net Income 174.2K 149.0K -3,026,461 -3,348,387
Gross Margin 99.1% 99.1% 42.9% 42.9%
Operating Margin 70.5% 63.5% -12.1% -11.8%
Profit Margin 0.1% 0.1% -13.6% -13.8%
Rev Growth +5.2% +5.2% +14.5% +15.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 42.46M 42.46M 13.67M 12.56M
Total Equity 102.96M 102.96M 33.53M 40.20M
D/E Ratio 0.41 0.41 0.41 0.31
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 136.06M 122.85M -4,014,681 -4,691,998
Free Cash Flow — — -2,971,274 -2,303,520